Free Trial

Beam Therapeutics (BEAM) Earnings Date, Estimates & Call Transcripts

Beam Therapeutics logo
$32.29 +3.39 (+11.74%)
Closing price 03:59 PM Eastern
Extended Trading
$31.31 -0.99 (-3.05%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Beam Therapeutics Earnings Summary

Beam Therapeutics released Q4 2025 earnings on February 24, 2026, reporting an EPS of $2.33, which topped analysts' consensus estimates of -$1.13 by $3.46. Quarterly revenue rose 280.3% year-over-year to $114.11 million, above analyst estimates of $13.22 million. With a trailing EPS of -$1.01, Beam Therapeutics' earnings are expected to remain at ($3.90) per share in the coming year.

Latest Q4
Earnings Date
Feb. 24Estimated
Consensus EPS
(Feb. 24)
-$1.13
Actual EPS
(Feb. 24)
$2.33 Beat By $3.46
Actual Revenue
(Feb. 24)
$114.11M

Q4 2025 Earnings Resources

Get Beam Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Beam Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

BEAM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BEAM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Beam Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20263-$1.30-$0.91-$1.11
Q2 20263-$1.45-$0.93-$1.18
Q3 20263-$1.61-$0.94-$1.24
Q4 20263-$1.72-$0.96-$1.28
FY 2026 12 -$6.08 -$3.74 -$4.80
Q1 20271-$0.90-$0.90-$0.90
Q2 20271-$0.90-$0.90-$0.90
Q3 20271-$0.85-$0.85-$0.85
Q4 20271-$0.87-$0.87-$0.87

Beam Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/24/2026Q4 2025-$1.13$2.33+$3.46$2.33$13.22M$114.11M
11/4/2025Q3 2025-$0.98-$1.10 -$0.12-$1.10$12.83M$9.70M
8/5/2025Q2 2025-$1.04-$1.00+$0.04-$1.00$13.29M$8.47M
5/6/2025Q1 2025-$1.11-$1.24 -$0.13-$1.24$14.69M$7.47M
2/25/2025Q4 2024-$1.25-$1.09+$0.16-$1.09$16.47M$30.00M
11/5/2024Q3 2024-$1.16-$1.17 -$0.01-$1.17$14.52M$14.30M
8/6/2024Q2 2024-$1.13-$1.11+$0.02-$1.11$14.18M$11.80M
5/7/2024Q1 2024-$1.42-$1.21+$0.21-$1.21$17.09M$7.40M

Data powered by Fiscal.ai.

Beam Therapeutics Earnings - Frequently Asked Questions

Beam Therapeutics (NASDAQ:BEAM) last announced its quarterly earning data on Tuesday, February 24, 2026. Learn more on BEAM's earnings history.

In the previous quarter, Beam Therapeutics (NASDAQ:BEAM) reported $2.33 earnings per share (EPS) to beat the analysts' consensus estimate of ($1.13) by $3.46. Learn more on analysts' earnings estimate vs. BEAM's actual earnings.

The conference call for Beam Therapeutics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Beam Therapeutics' latest earnings report can be read online.
Read Transcript

Beam Therapeutics (NASDAQ:BEAM) has a recorded annual revenue of $139.74 million.

Beam Therapeutics (NASDAQ:BEAM) has a recorded net income of -$79.99 million. BEAM has generated -$1.01 earnings per share over the last four quarters.

Beam Therapeutics' earnings are expected to stay at ($3.90) per share in the next year.


This page (NASDAQ:BEAM) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners